摘要
多囊卵巢综合征为育龄期妇女常见病,发病率高,且易造成月经紊乱及不孕。有学者运用中医、西医、中西医结合方式对多囊卵巢综合征发病机制及治疗进行了深入地探讨。西医主要从下丘脑-垂体-卵巢轴调节功能异常、高胰岛素血症和胰岛素抵抗、肾上腺内分泌功能异常、全身多系统多器官功能异常等方面阐述其病理机制,治疗上多采用激素干预、手术等方式;中医认为多囊卵巢综合征的病理机制多与肾、肝、脾功能失调及痰湿、血瘀相关,治疗方面以除湿等为主,治疗效果较好。中医、西医治疗多囊卵巢综合征各有其优势,二者结合是改善多囊卵巢综合征的重要治疗方式。
Polycystic ovary syndrome was a common disease in women of childbearing age, with a high incidence rate, and was prone to menstrual disorders and infertility. Some scholars were applied TCM, western medicine, and the integrated medicine to investigate the pathogenesis and treatment of polycystic ovary syndrome. Western medicine was mainly described the pathological mechanism of hypothalamic-pituitary-ovarian axis regulation dysfunction, hyperinsulinemia and insulin resistance, adrenal endocrine dysfunction,systemic multi-system and multiple organ dysfunction, and was applied hormone intervention and surgery to treatment. TCM was believed that the pathological mechanism was related to kidney, liver and spleen dysfunction, Tanshi( 痰湿) and Xueyu( 血瘀). The treatment of TCM was mainly dehumidification, with better effects. TCM and western medicine showed different advantages in treating polycystic ovary syndrome, those were an important treatment for improving polycystic ovary syndrome.
引文
[1]Ali Sami Gurbuza, Ruya Deveerb,cMert Kucukb, et al. Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology[J].Journal of Clinical Medicine Research,2016,8(05):396–401.
[2]乔杰,伊太郎.多囊卵巢综合征认知与对策[J].中国实用妇科与产科杂志,2013,11(02):842.
[3]DeepikaKrishna,SnehalDhoble,GauthamPraneesh,etal.Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic:A Randomized control trial[J].Journal of Human Reproductive Sciences,2016,9(03):164-172.
[4]SHI YY, ZHAO H, SHI Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome[J].Nat Genet,2012,44(9):1020-1025.
[5]YANG R,YANG S,LI R, et al. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome:a meta-analysis[J].Reproductive Biology and Endocrinology,2016,14(01):67.
[6]张珂.中西医结合治疗多囊卵巢综合征所致不孕的研究进展[J].云南中医中药杂志,2013,9(34):76-77.
[7]黄浓香,黄姣莲.克罗米芬联合人绒毛膜促性腺激素治疗PCOS疗效观察[J].中华全科医学,2013,11(06):905.
[8]刘晓莲.观察克罗米芬结合人绒毛膜促性腺激素(HCG)治疗多囊卵巢综合症的疗效[J].实用妇科内分泌杂志,2017,18(04):62-63.
[9]邓兵安.浅析中西医药物治疗多囊卵巢综合征的临床效果[J].内蒙古中医药,2016,35(11):65.
[10]文慧华.多囊卵巢综合征的中医体质辨识及证型的临床研究[J].中医临床研究,2018,10(20):11-15.
[11]邸莎,王雪娇,张和韡,等.中医辨证分型治疗PCOS近十年研究进展[J].环球中医药,2017,10(09):1143-1146.[1 2]张婷婷,王琳.多囊卵巢综合征治疗进展[J].实用中医药杂志,2012,3(15):249.
[13]包红霞.中医辨证多囊卵巢综合征临床分型研究进展[J].内蒙古中医药,2017,36(16):137-138.
[14]罗凌,陈娟.多囊卵巢综合征中西医结合分型治疗的临床观察[J].中外医学研究,2014,12(29):5-7.
[15]韦燕旋.浅谈多囊卵巢综合征之中医药治疗研究[J].按摩与康复医学,2015,20(06):17-18.
[16]丁彩飞,王晨晔,杨欣,等.苍附导痰汤加减方对多囊卵巢综合征不孕症患者子宫内膜容受性的影响[J].中国中西医结合杂志,2014,34(11):1297-1301.
[17]王璐.苍附导痰丸加减治疗肥胖型多囊卵巢综合征的临床观察[J].中医临床研究,2017,9(04):95-97.
[18]李修阳,徐琬梨,刘家义.启宫丸加味结合针灸治疗痰湿型多囊卵巢综合征26例疗效观察[J].山东中医杂志,2013,32(12):878-880.
[19]陈宇,任健,张宁,等.启宫丸对PCOS痰湿证患者IRS-2蛋白表达及酪氨酸磷酸化的影响[J].山东中医杂志,2015,34(02):92-93.
[20]周睿.中药温肾涤痰法为基础配合中药周期疗法治疗多囊卵巢综合征所致不孕[J].中外医学研究,2016,14(22):34-35.
[21]徐萌萌,傅金英.补肾健脾法治疗PCOS患者排卵障碍的临床研究[J].中医临床研究,2014,6(07):42-43.
[22]陈欣,宋岩,邓永志,等.补肾活血方对多囊卵巢综合征大鼠抗苗勒氏管激素作用[J].中医临床研究,2017,9(17):1-3.
[23]陈莉.穴位埋线对肥胖型多囊卵巢综合症患者的疗效观察[J].中医临床研究,2018,10(10):36-37.
[24]姚军强.半夏的药理作用及其临床配伍运用[J].中医研究,2013,26(02):3-5.
[25]张钟媛.茯苓药理作用研究进展[J].继续医学教育,2015,29(05):108-109.[2 6]姜雪,孙森凤,王悦,等.甘草药理作用研究进展[J].化工时刊,2017,31(07):25-28.
[27]邓爱平,李颖,吴志涛,等.苍术化学成分和药理的研究进展[J].中国中药杂志,2016,41(21):3904-3913.
[28]刘双,杨静,江振作,等.中药“神曲”发酵工艺及质量标准研究进展[J].天津中医药,2015,32(05):318-320.
[29]徐晓婷,邓志鹏,仲浩,等.香附化学成分及药理作用研究进展[J].齐鲁药事,2012,31(08):473-475.
[30]金玉青,洪远林,李建蕊,等.川芎的化学成分及药理作用研究进展[J].中药与临床,2013,4(03):44-48.
[31]潘炉群.中西医结合治疗多囊卵巢综合征致月经失调探讨[J].中国农村卫生事业管理,2015,4(35):519-521.
[32]崔明华,李韬,陈欣.中西医结合治疗多囊卵巢综合征所致不孕的效果探究[J].中西医结合心血管病杂志,2016,23(04):198.
[33]陈晓燕.二甲双胍联合中药对多囊卵巢综合征患者超声指标性激素及血清促炎因子的影响[J].中医临床研究,2018,10(18):81-84.
